Literature DB >> 17161865

Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.

Wee Beng Tan1, Shan Jiang, Yong Zhang.   

Abstract

Gene silencing using short interfering RNA (siRNA) is fast becoming an attractive approach to probe gene function in mammalian cells. Although there have been some success in the delivery of siRNA using various methods, tracking their delivery and monitoring their transfection efficiency prove to be hard without a suitable tracking agent. Therefore, a challenge lies with the design of an efficient and at the same time, self-tracking, transfection agent for RNA interference. In this paper, chitosan nanoparticles (NPs) with encapsulated quantum dots (QDs) were synthesized and used to deliver HER2/neu siRNA. Using such a construct, the delivery and transfection of the siRNA can be monitored by the presence of fluorescent QDs in the chitosan NPs. Targeted delivery of HER2 siRNA to HER2-overexpressing SKBR3 breast cancer cells was shown to be specific with chitosan/QD NP surface labeled with HER2 antibody targeting the HER2 receptors on SKBR3 cells. Gene-silencing effects of the conjugated siRNA was also established using the luciferase and HER2 ELISA assays. These self-tracking siRNA delivery NPs will also aid in the monitoring of future gene silencing studies in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161865     DOI: 10.1016/j.biomaterials.2006.11.018

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  64 in total

1.  FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERY.

Authors:  Gang Liu; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Nano Today       Date:  2010-12-01       Impact factor: 20.722

Review 2.  Quantum dot-based theranostics.

Authors:  Yi-Ping Ho; Kam W Leong
Journal:  Nanoscale       Date:  2009-10-06       Impact factor: 7.790

Review 3.  Preclinical and clinical development of siRNA-based therapeutics.

Authors:  Gulnihal Ozcan; Bulent Ozpolat; Robert L Coleman; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

Review 4.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

Review 5.  Liposomal siRNA nanocarriers for cancer therapy.

Authors:  Bulent Ozpolat; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Adv Drug Deliv Rev       Date:  2013-12-30       Impact factor: 15.470

Review 6.  Antibody-based imaging of HER-2: moving into the clinic.

Authors:  R E Wang; Y Zhang; L Tian; W Cai; J Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 7.  Bioconjugated quantum dots for in vivo molecular and cellular imaging.

Authors:  Andrew M Smith; Hongwei Duan; Aaron M Mohs; Shuming Nie
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

8.  Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging.

Authors:  Maksym V Yezhelyev; Lifeng Qi; Ruth M O'Regan; Shuming Nie; Xiaohu Gao
Journal:  J Am Chem Soc       Date:  2008-06-21       Impact factor: 15.419

9.  Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery.

Authors:  Theerasak Rojanarata; Praneet Opanasopit; Sunee Techaarpornkul; Tanasait Ngawhirunpat; Uracha Ruktanonchai
Journal:  Pharm Res       Date:  2008-06-18       Impact factor: 4.200

Review 10.  In vivo imaging of RNA interference.

Authors:  Hao Hong; Yin Zhang; Weibo Cai
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.